Cutaneous leishmaniasis in kidney transplant recipient

Fernandes, Ida Maria Maximina; Baptista, Maria Alice Sperto Ferreira; Barbon, T.R.A; Oliveira, Juliane; Correa-Oliveira, Rodrigo; Murai, Noriyuki; Camelo, F.; Ramalho, Horácio José; Abbud-Filho, Mário

doi:10.1016/s0041-1345(02)02611-8

Cited by 19 publications

(27 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Reports on CL reactivation have been described in the medical literature. These cases have been reported in kidney transplant patients receiving cyclosporine and prednisone treatment, 3–5 in patients treated with topical corticoids, 6 and in a patient with rheumatoid arthritis receiving prednisone and methotrexate treatment 7 . Nevertheless, there has been no report of CL reactivation related to systemic corticoid treatment.…”

Section: Discussionmentioning

confidence: 99%

“…1,2 There have been a few descriptions in the literature of cutaneous leishmaniasis (CL) reactivation associated with immunosuppressant drug use, but, as far as we know, there have been no reports of the occurrence of this event with systemic corticoid use. [3][4][5][6][7] We report the first case of CL reactivation associated exclusively with systemic corticosteroid treatment, in a female patient with rheumatoid arthritis who had been taking corticosteroids for years, and who presented with CL reactivation 2 years after lesion healing induced by specific treatment.…”

Section: Introductionmentioning

confidence: 96%

See 1 more Smart Citation

Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids – first report

et al. 2007

View full text Add to dashboard Cite

American tegumentary leishmaniasis (ATL), an endemic anthropozoonosis in various countries in the world, is caused by parasites of the genus Leishmania. Despite reports on ATL reactivation as a result of immunosuppression, to the best of our knowledge, this paper describes the first case of ATL reactivation in its localized form (cutaneous leishmaniasis) associated with the administration of systemic corticosteroids. The possible action of corticosteroids on the host immune response to the parasite in patients with localized cutaneous leishmaniasis is discussed. This report demonstrates the possibility of ATL reactivation in patients using corticosteroids, an observation that should be considered in individuals treated with this medication.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 96%

Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids – first report

et al. 2007

View full text Add to dashboard Cite

show abstract

“…In the last two decades, the prevelance of leishmaniasis has increased significantly in transplant recipients because of the increasing frequency of organ transplantations (1). To date, seven organ transplant recipients with cutaneous leishmaniasis (7–9, 13–16) have been reported; of those four had concurrent visceral leishmaniasis (7–9, 16).…”

Section: Discussionmentioning

confidence: 99%

Liver transplant recipient with concomitant cutaneous and visceral leishmaniasis

Özcan

Seckın

Allahverdiyev

et al. 2007

Pediatric Transplantation

View full text Add to dashboard Cite

Diagnosis of leishmaniasis in immunosuppressed patients may be a serious challenge for physicians because of the major clinical and laboratory differences with immunocompetent patients. In immunosuppressed patients, the disease is characterized usually by disseminated visceral involvement, atypical cutaneous lesions and persistent negativity of diagnostic tests. Here, we report an eight-yr-old liver transplant recipient with concomitant cutaneous and visceral leishmaniasis in whom the cutaneous lesion led to the diagnosis of systemic involvement.

show abstract

“…Leishmania species Insect bite Numerous SOs [105][106][107][108][109][110][111][112][113][114][115] and HSC [116] No Rodents, dogs Microsporidia Ingestion Kidney [117], kidney-pancreas [117], and BM [118,119] No Numerous…”

Section: Echinococcus Granulosusmentioning

confidence: 99%

“…Patients who undergo HSCT appear to be rarely affected [116]. Cutaneous leishmaniasis has been reported in a handful of cases of SOT, some with concomitant visceral involvement [106][107][108][109][110]; mucosal disease has also been reported infrequently [111][112][113][114][115].…”

Section: Parasitic Infectionmentioning

confidence: 99%

Zoonoses in Solid-Organ and Hematopoietic Stem Cell Transplant Recipients

Kotton

2007

Clinical Infectious Diseases

139

105

View full text Add to dashboard Cite

Numerous reports exist of the transmission of zoonoses to humans during and after solid-organ and hematopoietic stem cell transplantation. Donor-derived infections of numerous etiologies, including West Nile virus infection, Chagas disease, toxoplasmosis, rabies, lymphocytic choriomeningitis virus infection, and infection due to Brucella species have been reported. Most zoonoses occur as a primary infection after transplantation, and immunocompromised patients are more likely to experience significant morbidity and mortality from these infections. Risks of zoonotic infection in the posttransplantation period could be reduced by patient education. Increased recognition of the risks of zoonoses, as well as the advent of molecular biology-based testing, will potentially augment diagnostic aptitude. Documented zoonotic infection as it affects transplantation will be the primary focus of this review.

show abstract

Cutaneous leishmaniasis in kidney transplant recipient

Cited by 19 publications

References 10 publications

Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids – first report

Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids – first report

Liver transplant recipient with concomitant cutaneous and visceral leishmaniasis

Zoonoses in Solid-Organ and Hematopoietic Stem Cell Transplant Recipients

Contact Info

Product

Resources

About